☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Biliary Atresia
Albireo's A4250 Receives FDA's Orphan Drug Designation (ODD) for Biliary Atresia
January 23, 2019
Albireo's A4250 Receives EU Orphan Drug Designation (ODD) for Biliary Atresia
December 19, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
